· National Medical Insurance Variety National Essential Drug Variety
· The only bromhexine product that has entered the "China List of Listed Drugs"
· Consensus recommendation by many guidelines at home and abroad

Specification: 8mg
Drug category: Western medicine
National Health Insurance: Category A

Indications: This product is mainly used for patients with viscous phlegm caused by chronic bronchitis and asthma.

Pharmacological effects: This product directly acts on the bronchial glands, which can release the lysosomes of the mucus secreting cells, thereby depolymerizing the mucopolysaccharides in the mucus and reducing the viscosity of the mucus; it can also cause the respiratory tract to secrete low-viscosity microbes. Molecular mucin that thins sputum and makes it easier to cough up.